Possible contribution of XYY syndrome to neuroleptic malignant syndrome in a child receiving quetiapine
- Promazine. // Reactions Weekly;Jul2014, Vol. 1509 Issue 1, p28
The article presents a case study of a 61-year-old man who was diagnosed with neuroleptic syndrome while being medicated with promazine for agitation.
- Antipsychotics/metoclopramide. // Reactions Weekly;3/9/2013, Issue 1443, p8
An abstract of the article "Elevated creatine kinase does not necessarily correspond temporally with onset of muscle rigidity in neuroleptic malignant syndrome: A report of two cases," by K. Nisijima is presented.
- Massive increase in serum creatine kinase during olanzapine and quetiapine treatment, not during treatment with clozapine. Boot, Erik; de Haan, Lieuwe // Psychopharmacology;2000, Vol. 150 Issue 3, p347
Describes a case of a 19-year-old African-Caribbean man in which there was a massive creatine kinase (CPK) increase during olanzapine treatment without symptoms of neuroleptic malignant syndrome (NMS) which disappeared during treatment with clozapine. Several publications that describes CPK...
- Haloperidol/quetiapine. // Reactions Weekly;4/25/2009, Issue 1249, p23
The article describes the clinical cases of two patients who developed neuroleptic malignant syndrome while under haloperidol and quetiapine treatment regimen. The first patient is a 52-year-old man who received intramascular (IM) haloperidol to address his agitation, while the other patient is...
- Elevated creatine kinase does not necessarily correspond temporally with onset of muscle rigidity in neuroleptic malignant syndrome: a report of two cases. Nisijima, Koichi // Neuropsychiatric Disease & Treatment;2012 Part 2, Vol. 8, p615
Neuroleptic malignant syndrome is an uncommon but dangerous complication of antipsychotic drugs, characterized by clinical symptoms that include hyperthermia, severe muscle rigidity, autonomic dysfunction, and altered mental state. Serum creatine kinase (CK) elevation occurs in over 90% of...
- Catatonia: Harbinger of the Neuroleptic Malignant Syndrome. White, Denise A. C.; Robins, Ashley H. // British Journal of Psychiatry;Mar91, Vol. 158, p419
Five consecutive cases of the NMS are presented, in all of which a catatonic state preceded the onset of the condition. Catatonia would appear to represent a highly significant risk factor for the NMS and a possible causal link between the two disorders is suggested.
- Neuroleptic malignant-like syndrome with a slight elevation of creatine-kinase levels and respiratory failure in a patient with Parkinson's disease. Li Wei; Yinghui Chen // Patient Preference & Adherence;2014, Vol. 8, p271
Neuroleptic malignant-like syndrome (NMLS) is a rare but catastrophic complication of drug treatment for Parkinson's disease (PD). Sudden withdrawal and abrupt reduction of antiparkinsonian drugs are major risk factors. Just as its name suggests, the clinical features of NMLS are similar to...
- Bir Ã§ocukta risperidon aÅŸÄ±rÄ± dozuna baÄŸlÄ± geliÅŸen nÃ¶roleptik malign sendrom: Bir olgu sunumu. Saltik, Sema; Basgul, Saziye Senem // Klinik Psikofarmakoloji Bulteni;Mar2012, Vol. 22 Issue 1, p75
Neuroleptic malignant syndrome is a rare, but potentially fatal idiosyncratic reaction to antipsychotic drugs that manifests itself consistently with hyperthermia, muscle rigidity, akinesia, altered mental state, autonomic instability, high creatine phosphokinase levels, and leukocytosis. We...
- Antipsychotics/valproic acid. // Reactions Weekly;12/5/2009, Issue 1281, p7
The article describes the clinical cases of three male patients who were hospitalized for manic episodes with psychosis developed neuroleptic malignant syndrome (NMS) while receiving antipsychotics. After five to six days of receiving antipsychotic medications the patients showed similar...